Barbara O’Brien
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
- Drug-Induced Adverse Reactions
Papers in
-
- Antibiotic Use and Resistance 2
- Health 3
- Religion, Spirituality, and Psychology 3
- Co-authors
- G. ArcieriAllen HeydNancy BeckerEric C. GriffithP. SchachtElizabeth C. GriffithColleen DoyleChristopher Neumann
- Journals
- Nursing Administration Quarterly (4 papers)Reviews on Recent Clinical Trials (2 papers)Controlled Clinical Trials (2 papers)Current Opinion in Critical Care (1 paper)Digestive Diseases (1 paper)
- Partner nations
- United StatesGermanySweden
In The Last Decade
Barbara O’Brien
21 papers receiving 410 citations
Peers
Comparison fields: 5 of 94
- Molecular Medicine 78
- Pharmacology 224
- Applied Microbiology and Biotechnology 11
- Clinical Biochemistry 33
- Research and Theory 4
Countries citing papers authored by Barbara O’Brien
This map shows the geographic impact of Barbara O’Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara O’Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara O’Brien more than expected).
Fields of papers citing papers by Barbara O’Brien
This network shows the impact of papers produced by Barbara O’Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara O’Brien. The network helps show where Barbara O’Brien may publish in the future.
Co-authors
The 25 scholars most cited alongside Barbara O’Brien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 5 | |
| 2 | 2015 | 1 | |
| 3 | 2002 | 4 | |
| 4 | 2001 | 13 | |
| 5 | 2000 | 11 | |
| 6 | 2000 | 9 | |
| 7 | 2000 | 16 | |
| 8 | 2000 | 21 | |
| 9 | An evaluation of rectal mucosal proliferation measure variability sources in the polyp prevention trial: can we detect informative differences among individuals' proliferation measures amid the noise? | 1998 | 10 |
| 10 | 1998 | 1 | |
| 11 | 1997 | 8 | |
| 12 | 1996 | 12 | |
| 13 | 1991 | 16 | |
| 14 | 1989 | 45 | |
| 15 | 1988 | 73 | |
| 16 | 1988 | 19 | |
| 17 | Ciprofloxacin: an update on clinical experience. | 1987 | 109 |
| 18 | 1986 | 55 | |
| 19 | Patterns of European Diagnoses and Prescribing | 1984 | 16 |
| 20 | 1954 | 1 |
About Barbara O’Brien
Barbara O’Brien is a scholar working on Applied Microbiology and Biotechnology, Health, Pharmacology, Toxicology and Oncology, having authored 22 papers that have together received 450 indexed citations. Recurring topics across this work include Colorectal Cancer Screening and Detection (5 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Genetic factors in colorectal cancer (4 papers), Religion, Spirituality, and Psychology (3 papers), Ethics in Clinical Research (3 papers), Global Cancer Incidence and Screening (2 papers), Antibiotic Use and Resistance (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Molecular Medicine (78 citations), Pharmacology (224 citations), Applied Microbiology and Biotechnology (11 citations), Clinical Biochemistry (33 citations) and Research and Theory (4 citations). Barbara O’Brien has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include G. Arcieri, Allen Heyd, Nancy Becker, Eric C. Griffith, P. Schacht, Elizabeth C. Griffith, Colleen Doyle, Christopher Neumann, Barbara Esposito and Darwin R. Labarthe. Their work appears in journals such as Nursing Administration Quarterly, Reviews on Recent Clinical Trials, Controlled Clinical Trials, Current Opinion in Critical Care and Digestive Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.